343 related articles for article (PubMed ID: 32454795)
1. Notch-Hes1 Signaling Regulates IL-17A
Wang Y; Li X; Xing X; Xue H; Qi R; Ji H; Ma L
Mediators Inflamm; 2020; 2020():8297134. PubMed ID: 32454795
[TBL] [Abstract][Full Text] [Related]
2. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
3. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
4. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
5. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
6. LY294002 ameliorates psoriatic skin inflammation in mice via blocking the Notch1/Hes1-PTEN/AKT/IL-17A feedback loop.
Lin Y; Zhu X; Li Y; Dou Y; Wang J; Qi R; Ma L
Clin Exp Immunol; 2023 Jul; 213(1):114-124. PubMed ID: 36840628
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
[TBL] [Abstract][Full Text] [Related]
8. Notch1/Hes1‑PTEN/AKT/IL‑17A feedback loop regulates Th17 cell differentiation in mouse psoriasis‑like skin inflammation.
Lin YW; Li XX; Fu FH; Liu B; Xing X; Qi R; Ma L
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35582997
[TBL] [Abstract][Full Text] [Related]
9. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
12. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
14. Notch1 Signaling Regulates the Th17/Treg Immune Imbalance in Patients with Psoriasis Vulgaris.
Ma L; Xue H; Gao T; Gao M; Zhang Y
Mediators Inflamm; 2018; 2018():3069521. PubMed ID: 29686529
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23/Th17 cell axis.
Song C; Yang C; Meng S; Li M; Wang X; Zhu Y; Kong L; Lv W; Qiao H; Sun Y
J Ethnopharmacol; 2021 Dec; 281():114571. PubMed ID: 34464701
[TBL] [Abstract][Full Text] [Related]
16. Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23/Th17 axis via regulating Jak2/Stat3 signaling pathway.
Zhang M; Li N; Cai R; Gu J; Xie F; Wei H; Lu C; Wu D
Phytother Res; 2021 Aug; 35(8):4526-4537. PubMed ID: 34008239
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
18. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
19. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
20. Double-negative T cells ameliorate psoriasis by selectively inhibiting IL-17A-producing γδ
Wei Y; Sun G; Yang Y; Li M; Zheng S; Wang X; Zhong X; Zhang Z; Han X; Cheng H; Zhang D; Mei X
J Transl Med; 2024 Apr; 22(1):328. PubMed ID: 38566145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
